Replies to post #807633 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Sort of, but your point wasn’t about needing to beat the deadline.

Instead, according to AI:

The MHRA has officially confirmed (as of October 2025) that they are adopting the Revised Variations Framework on January 15, 2026.
• The Technical Reality: This is a major technical migration. Any drug file "in-process" that isn't granted by the 15th has to be transitioned into a new electronic Application Form (eAF) system with entirely new change codes.